KPV

Chemical Makeup:

• Molecular Formula: C16, H30, N4, O4
• Molecular Weight: 342.43 g/mol
• Synonyms: a-MSH(11-13), ACTH(11-13), C-terminal a-MSH fragment

Sequence:

• Lys-Pro-Val

[[KPV] and Intestinal Inflammation (IBD)]

Research utilizing murine models of colitis has focused on [KPV]'s interaction with the PepT1 transporter, which is often overexpressed in inflamed intestinal tissues. In studies involving dextran sulfate sodium (DSS)-induced colitis, oral administration of [KPV] was observed to reduce inflammation and maintain histological integrity. Data suggests that the peptide’s efficacy in these models is linked to its ability to downregulate pro-inflammatory signaling pathways specifically within intestinal epithelial cells and macrophages.

[[KPV] and Antimicrobial Activity]

In vitro assays have explored the bactericidal and fungicidal potential of [KPV]. The peptide has been shown to exhibit antimicrobial activity against Staphylococcus aureus and Candida albicans. Mechanisms proposed include the disruption of microbial membrane stability and the modulation of the host immune response to infection. Unlike traditional antibiotics, [KPV] appears to enhance the host's innate defense mechanisms without significant cytotoxicity to mammalian cells.

[[KPV] and Wound Healing]

Studies dealing with cutaneous injury suggest that [KPV] may accelerate the process of re-epithelialization. In experimental wound models, the presence of the peptide was correlated with a reduction in neutrophil infiltration and an earlier transition from the inflammatory phase to the proliferative phase of healing. Furthermore, research indicates a potential reduction in scar formation, hypothesized to be a result of modulated collagen deposition and decreased fibrotic signaling.

[[KPV] and Dermatological Conditions]

Due to its lack of melanotropic (pigment-inducing) activity, [KPV] has been investigated for conditions such as psoriasis and atopic dermatitis. Animal research suggests that topical application may reduce edema and erythema associated with contact dermatitis. The mechanism is believed to involve the suppression of cutaneous lymphocyte activity and the inhibition of mast cell degranulation, offering a targeted approach to skin inflammation without the steroidal side effects typically observed in dermatological treatments.

If you're not 100% satisfied within the first 30 days, just send it back to us and we'll give you a full refund.

No need to worry about the return shipping - we've got you covered!

We offer fast and reliable shipping on all orders. You can expect to receive it within 7-12 business days based on your location.

Please contact our customer service team for assistance if you have any questions or concerns about your shipment.

Side Effects:

In rodent studies, [KPV] has demonstrated a favorable safety profile. Notably, it does not induce melanogenesis (skin darkening), a common side effect of full-length a-MSH analogues. High-dose studies in mice did not reveal acute toxicity or significant alterations in blood pressure. However, long-term safety data in human subjects remains unavailable.

Disclaimer:

For Research Use Only. Not for Human Consumption. This product is intended solely for laboratory research and development purposes. It is not intended for diagnostic, therapeutic, or clinical use in humans or animals.